FDA-Drug2024-03-06Class II
Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.
SUN PHARMACEUTICAL INDUSTRIES INC
Hazard
Failed Dissolution Specifications: Out of specification for dissolution.
Sold states
Nationwide in the U.S.
Affected count
54,960 bottles
Manufactured in
2 Independence Way, Princeton, NJ, United States
Products
Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0350-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief